NCT02044991

Brief Summary

The purpose of this study is to see if pelvic girdle pain can be more effectively treated with the use of injectable anti-inflammatory medication plus physical therapy compared with physical therapy and a saline injection.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Oct 2013

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 24, 2013

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 17, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 24, 2014

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 22, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 22, 2017

Completed
3 months until next milestone

Results Posted

Study results publicly available

May 12, 2017

Completed
Last Updated

August 8, 2018

Status Verified

July 1, 2018

Enrollment Period

3.3 years

First QC Date

January 17, 2014

Results QC Date

April 3, 2017

Last Update Submit

July 11, 2018

Conditions

Keywords

SciaticaPelvic girdle pain

Outcome Measures

Primary Outcomes (1)

  • Change in Pain

    Pain is measured using the Pain Numeric Rating Scale (NRS), which ranges from 0 to 10 with higher scores indicating greater pain. This measure is recorded at baseline (0 weeks) and 8 weeks. The change in pain between these two time points (i.e., the difference score) is compared between the two groups.

    8 weeks

Secondary Outcomes (2)

  • Pelvic Functioning

    8 weeks

  • Disability

    8 weeks

Study Arms (2)

Treatment

ACTIVE COMPARATOR

Participants randomized to this arm will receive a corticosteroid. This is 40mg of a non-fluorinated injectable glucocorticoid, methylprednisolone acetate (1cc) combined with 1cc of 1% Lidocaine

Drug: Corticosteroid

Placebo

PLACEBO COMPARATOR

Participant's randomized to this condition will receive a placebo injection once weekly

Drug: Placebo Injection

Interventions

40mg of a non-fluorinated injectable glucocorticoid, methylprednisolone acetate (1cc) combined with 1cc of 1% Lidocaine

Also known as: Medrol
Treatment

A placebo injection

Also known as: Saline
Placebo

Eligibility Criteria

Age21 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women who are not doing other therapies for pain (physical therapy, chiropractic management, pool)
  • Women between age 21 and 50 who plan to deliver at Loyola or Gottlieb
  • Pain Numeric Rating Scale (NRS) on average of greater than or equal to 5/10 at Visit 1
  • Pain must be between the upper level of the iliac crests and the gluteal folds in conjunction with or separately from pain in the pubic symphysis and influenced by position and locomotion
  • /4 positive physical examination tests on the symptomatic side including the P4 test, the LDL test, pubic symphysis palpation and the acute straight leg rise (ASLR)

You may not qualify if:

  • Women presenting with PGP in the first or third trimester (\<13 weeks gestation or \>28 weeks gestation)
  • Women with pubic symphysis (anterior) pain alone
  • Women who do not plan to deliver a baby at Loyola or Gottlieb
  • Pain above the upper level of the iliac crest
  • History of lumbar or pelvic fracture, neoplasm, inflammatory disease, active urogenital infection or active gastrointestinal illness, current physical therapy or other therapies for PGP, or previous surgery of the lumbar spine, pelvic girdle, hip joint or femur
  • History or signs of radiculopathy or other systemic neurologic disease
  • Women with diabetes or gestational diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Loyola University Health System

Maywood, Illinois, 60153, United States

Location

Related Publications (28)

  • Wu WH, Meijer OG, Uegaki K, Mens JM, van Dieen JH, Wuisman PI, Ostgaard HC. Pregnancy-related pelvic girdle pain (PPP), I: Terminology, clinical presentation, and prevalence. Eur Spine J. 2004 Nov;13(7):575-89. doi: 10.1007/s00586-003-0615-y. Epub 2004 Aug 27.

    PMID: 15338362BACKGROUND
  • Ekman EF, Koman LA. Acute pain following musculoskeletal injuries and orthopaedic surgery: mechanisms and management. Instr Course Lect. 2005;54:21-33.

    PMID: 15948432BACKGROUND
  • Kristiansson P, Svardsudd K, von Schoultz B. Serum relaxin, symphyseal pain, and back pain during pregnancy. Am J Obstet Gynecol. 1996 Nov;175(5):1342-7. doi: 10.1016/s0002-9378(96)70052-2.

    PMID: 8942512BACKGROUND
  • Stapleton DB, MacLennan AH, Kristiansson P. The prevalence of recalled low back pain during and after pregnancy: a South Australian population survey. Aust N Z J Obstet Gynaecol. 2002 Nov;42(5):482-5. doi: 10.1111/j.0004-8666.2002.00482.x.

    PMID: 12495090BACKGROUND
  • Gutke A, Josefsson A, Oberg B. Pelvic girdle pain and lumbar pain in relation to postpartum depressive symptoms. Spine (Phila Pa 1976). 2007 Jun 1;32(13):1430-6. doi: 10.1097/BRS.0b013e318060a673.

    PMID: 17545912BACKGROUND
  • Brynhildsen J, Hansson A, Persson A, Hammar M. Follow-up of patients with low back pain during pregnancy. Obstet Gynecol. 1998 Feb;91(2):182-6. doi: 10.1016/s0029-7844(97)00630-3.

    PMID: 9469272BACKGROUND
  • Stuge B, Hilde G, Vollestad N. Physical therapy for pregnancy-related low back and pelvic pain: a systematic review. Acta Obstet Gynecol Scand. 2003 Nov;82(11):983-90. doi: 10.1034/j.1600-0412.2003.00125.x.

    PMID: 14616270BACKGROUND
  • Stuge B, Laerum E, Kirkesola G, Vollestad N. The efficacy of a treatment program focusing on specific stabilizing exercises for pelvic girdle pain after pregnancy: a randomized controlled trial. Spine (Phila Pa 1976). 2004 Feb 15;29(4):351-9. doi: 10.1097/01.brs.0000090827.16926.1d.

    PMID: 15094530BACKGROUND
  • Albert H, Godskesen M, Westergaard J. Prognosis in four syndromes of pregnancy-related pelvic pain. Acta Obstet Gynecol Scand. 2001 Jun;80(6):505-10.

    PMID: 11380285BACKGROUND
  • Stuge B, Veierod MB, Laerum E, Vollestad N. The efficacy of a treatment program focusing on specific stabilizing exercises for pelvic girdle pain after pregnancy: a two-year follow-up of a randomized clinical trial. Spine (Phila Pa 1976). 2004 May 15;29(10):E197-203. doi: 10.1097/00007632-200405150-00021.

    PMID: 15131454BACKGROUND
  • Elden H, Fagevik-Olsen M, Ostgaard HC, Stener-Victorin E, Hagberg H. Acupuncture as an adjunct to standard treatment for pelvic girdle pain in pregnant women: randomised double-blinded controlled trial comparing acupuncture with non-penetrating sham acupuncture. BJOG. 2008 Dec;115(13):1655-68. doi: 10.1111/j.1471-0528.2008.01904.x. Epub 2008 Oct 15.

    PMID: 18947338BACKGROUND
  • Haugland KS, Rasmussen S, Daltveit AK. Group intervention for women with pelvic girdle pain in pregnancy. A randomized controlled trial. Acta Obstet Gynecol Scand. 2006;85(11):1320-6. doi: 10.1080/00016340600780458.

    PMID: 17091411BACKGROUND
  • Bastiaenen CH, de Bie RA, Wolters PM, Vlaeyen JW, Leffers P, Stelma F, Bastiaanssen JM, Essed GG, van den Brandt PA. Effectiveness of a tailor-made intervention for pregnancy-related pelvic girdle and/or low back pain after delivery: short-term results of a randomized clinical trial [ISRCTN08477490]. BMC Musculoskelet Disord. 2006 Feb 27;7:19. doi: 10.1186/1471-2474-7-19.

    PMID: 16504165BACKGROUND
  • Lin J, Fessell DP, Jacobson JA, Weadock WJ, Hayes CW. An illustrated tutorial of musculoskeletal sonography: part I, introduction and general principles. AJR Am J Roentgenol. 2000 Sep;175(3):637-45. doi: 10.2214/ajr.175.3.1750637. No abstract available.

    PMID: 10954443BACKGROUND
  • Le Goff B, Berthelot JM, Maugars Y. Ultrasound assessment of the posterior sacroiliac ligaments. Clin Exp Rheumatol. 2011 Nov-Dec;29(6):1014-7. Epub 2011 Dec 22.

    PMID: 22206650BACKGROUND
  • Pekkafahli MZ, Kiralp MZ, Basekim CC, Silit E, Mutlu H, Ozturk E, Kizilkaya E, Dursun H. Sacroiliac joint injections performed with sonographic guidance. J Ultrasound Med. 2003 Jun;22(6):553-9. doi: 10.7863/jum.2003.22.6.553.

    PMID: 12795552BACKGROUND
  • Schull WJ, Otake M. Cognitive function and prenatal exposure to ionizing radiation. Teratology. 1999 Apr;59(4):222-6. doi: 10.1002/(SICI)1096-9926(199904)59:43.0.CO;2-M.

    PMID: 10331523BACKGROUND
  • Ruiz-Irastorza G, Khamashta MA. Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol. 2009 Aug;23(4):575-82. doi: 10.1016/j.berh.2009.04.004.

    PMID: 19591786BACKGROUND
  • Baer AN, Witter FR, Petri M. Lupus and pregnancy. Obstet Gynecol Surv. 2011 Oct;66(10):639-53. doi: 10.1097/OGX.0b013e318239e1ee.

    PMID: 22112525BACKGROUND
  • Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004454. doi: 10.1002/14651858.CD004454.pub2.

    PMID: 16856047BACKGROUND
  • Ostensen M, Ramsey-Goldman R. Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options? Drug Saf. 1998 Nov;19(5):389-410. doi: 10.2165/00002018-199819050-00006.

    PMID: 9825952BACKGROUND
  • Cole BJ, Schumacher HR Jr. Injectable corticosteroids in modern practice. J Am Acad Orthop Surg. 2005 Jan-Feb;13(1):37-46. doi: 10.5435/00124635-200501000-00006.

    PMID: 15712981BACKGROUND
  • Kumar N, Newman RJ. Complications of intra- and peri-articular steroid injections. Br J Gen Pract. 1999 Jun;49(443):465-6.

    PMID: 10562748BACKGROUND
  • Slotkoff AT, Katz P. Approach to the patient with rheumatoid arthritis. Adv Intern Med. 1994;39:197-240.

    PMID: 7908157BACKGROUND
  • Plastaras CT, Joshi AB, Garvan C, Chimes GP, Smeal W, Rittenberg J, Lento P, Stanos S, Fitzgerald C. Adverse events associated with fluoroscopically guided sacroiliac joint injections. PM R. 2012 Jul;4(7):473-8. doi: 10.1016/j.pmrj.2012.02.001. Epub 2012 Apr 28.

    PMID: 22543036BACKGROUND
  • Jacobs JW, Michels-van Amelsfort JM. How to perform local soft-tissue glucocorticoid injections? Best Pract Res Clin Rheumatol. 2013 Apr;27(2):171-94. doi: 10.1016/j.berh.2013.03.003.

    PMID: 23731930BACKGROUND
  • Elimian A, Goodman JR, Knudtson E, Wagner A, Wilson P, Williams M. Local anesthesia and pain perception during amniocentesis: a randomized double blind placebo-controlled trial. Prenat Diagn. 2013 Dec;33(12):1158-61. doi: 10.1002/pd.4214. Epub 2013 Sep 1.

    PMID: 23939867BACKGROUND
  • Edelman A, Nichols MD, Leclair C, Astley S, Shy K, Jensen JT. Intrauterine lidocaine infusion for pain management in first-trimester abortions. Obstet Gynecol. 2004 Jun;103(6):1267-72. doi: 10.1097/01.AOG.0000127981.53911.0e.

    PMID: 15172863BACKGROUND

MeSH Terms

Conditions

Pelvic Girdle PainSciatica

Interventions

Adrenal Cortex HormonesMethylprednisoloneSodium Chloride

Condition Hierarchy (Ancestors)

Musculoskeletal PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPelvic PainSciatic NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNeuralgia

Intervention Hierarchy (Ancestors)

HormonesHormones, Hormone Substitutes, and Hormone AntagonistsPrednisolonePregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Limitations and Caveats

The trial was terminated in February 2017 due to poor recruitment

Results Point of Contact

Title
Colleen Fitzgerald, M.D., M.S.
Organization
Loyola University

Study Officials

  • Colleen Fitzgerald, MD

    Loyola Univ Med Cntr-

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are assigned to receive either an injection of methylprednisolone acetate plus lidocaine or to receive an injection of saline with lidocaine using a randomized block design with a 1:1 allocation.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D., Associate Professor

Study Record Dates

First Submitted

January 17, 2014

First Posted

January 24, 2014

Study Start

October 24, 2013

Primary Completion

February 22, 2017

Study Completion

February 22, 2017

Last Updated

August 8, 2018

Results First Posted

May 12, 2017

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

There is no plan to share individual participant data

Locations